Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Southern Acids (M)

Market Cap 415M 102M 87.99M 80.9M 76.14M 143M 9.63B 144M 959M 373M 4.72B 383M 375M 16.34B P/E 2024
32.3x
P/E 2025 11.4x
Enterprise Value 48.03M 11.81M 10.19M 9.37M 8.81M 16.56M 1.11B 16.7M 111M 43.21M 547M 44.32M 43.37M 1.89B EV / Sales 2024
0.07x
EV / Sales 2025 0.05x
Free-Float
26.64%
Yield 2024
1.55%
Yield 2025 1.64%
Current month-1.26%
1 month-1.88%
3 months+2.95%
6 months+2.95%
Current year-1.26%
1 week 3.14
Extreme 3.14
3.14
1 month 3.1
Extreme 3.1
3.29
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 15/07/2015
Director of Finance/CFO 58 01/10/2013
Chief Tech/Sci/R&D Officer 38 16/07/2014
Director TitleAgeSince
Director/Board Member 66 10/08/2005
Director/Board Member 59 20/03/2012
Chairman 79 15/07/2015
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+1.29%-6.82% 106M
-0.59%-1.17%-2.67%+330.17% 5.15B
-0.70%+1.15%+12.80%+95.29% 1.69B
-0.98%-11.39%+18.10%+54.21% 736M
-2.08%-2.31%+58.23%+21.09% 718M
-2.69%-7.50%-23.52%-28.55% 529M
-0.16%+1.64%+24.35%+94.34% 525M
-0.33%+1.76%+87.53%+18.66% 483M
+0.05%+1.68%+3.20%+1.19% 365M
+0.36%-2.63%+28.53%+58.68% 298M
Average -0.63%-0.77%+20.78%+63.83% 1.06B
Weighted average by Cap. -0.62%-1.29%+10.89%+186.59%

Financials

2024 2025
Net sales 920M 226M 195M 179M 169M 317M 21.35B 320M 2.13B 828M 10.48B 849M 831M 36.25B 1.11B 272M 235M 216M 203M 381M 25.66B 385M 2.56B 995M 12.59B 1.02B 999M 43.56B
Net income 13.63M 3.35M 2.89M 2.66M 2.5M 4.7M 316M 4.74M 31.5M 12.26M 155M 12.58M 12.31M 537M 36.7M 9.02M 7.78M 7.16M 6.74M 12.66M 851M 12.76M 84.8M 33.02M 418M 33.86M 33.14M 1.45B
Net Debt -372M -91.5M -78.93M -72.57M -68.31M -128M -8.63B -129M -860M -335M -4.24B -343M -336M -14.66B -367M -90.19M -77.8M -71.53M -67.33M -127M -8.51B -128M -848M -330M -4.18B -338M -331M -14.45B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,683
Date Price Change Volume
16/06/26 3.140 RM 0.00% 1,000
  1. Stock Market
  2. Stocks
  3. 5134 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!